As pipelines diversify and new conjugation approaches emerge, facilities designed around today’s processes must be prepared ...
The distinctive properties of USP's mAb reference standards show utility for qualifying and monitoring methods for thermal ...
During our conversation, Seyf discussed his company’s involvement in the Australian ecosystem and how Australia is expanding ...
Connecting existing downstream steps delivers the value of continuous bioprocessing, says executive Jon Coffman at BioProcess ...
The physics that dictate this field’s timelines remain unforgiving. Radiopharmaceuticals cannot be inventoried the way ...
Autolomous CEO Alexander Seyf explains why collaboration, not competition, could unlock progress in cell and gene therapy ...
Reformatting historical data and getting scientists to agree on how to generate it are among the biggest hurdles in hybrid ...
NIBRT and San Jacinto College's biotech center in Houston train students for in-demand biomanufacturing and cell and gene therapy careers.
Ultimately, the discussion suggested that progress will come not from replacing CHO wholesale, but from pairing earlier, ...
After a “regular review of its global operations” the firm will divest the Waterford facility by 2026. The business will be gradually transferred to its 37,000-square-meter aseptic operations facility ...
Eli Lilly and Company announced a $3 billion expansion to its injectable product manufacturing site. The facility produces glucagon-like peptide-1 (GLP-1) drug products, which are used to treat ...
EMD Millipore Introduces the Mobius® 2000 Liter Single-Use Bioreactor with Industry-leading Design for Ease-of-Use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results